| Segment Reporting |
The Company’s CODM is regularly provided with entity-wide expense categories similar to those found in the consolidated statements of operations, as well as the following (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Revenue: | | | | | | | | | Product sales, net | $ | 176,243 | | | $ | 127,785 | | | $ | 336,125 | | | $ | 239,370 | | | | | | | | | | | | | | | | | | | Less: | | | | | | | | | Cost of sales (excluding intangible amortization) | 23,663 | | | 17,527 | | | 45,783 | | | 34,651 | | | General and administrative expenses (excluding stock-based compensation) | 17,378 | | | 13,090 | | | 36,553 | | | 24,771 | | | Commercialization and Medical Affairs expenses (excluding stock-based compensation) | 48,204 | | | 39,590 | | | 92,422 | | | 75,372 | | | Research and development expenses (excluding stock-based compensation) | 76,301 | | | 38,443 | | | 150,022 | | | 74,258 | | | Acquired IPR&D | 16,435 | | | — | | | 742,737 | | | 5,000 | | | Stock-based compensation | 30,114 | | | 18,230 | | | 87,240 | | | 33,702 | | | Intangible amortization | 6,685 | | | 5,894 | | | 13,370 | | | 11,788 | | | Loss from operations | $ | (42,537) | | | $ | (4,989) | | | $ | (832,002) | | | $ | (20,172) | |
|